Advanced Micro Devices Inc. (0QZD)
London Exchange · UK · prices in USD · close of 23 Oct 2026
Key indicators
| Last close | USD 515.85 |
|---|---|
| 52-week range | 159.70 – 658.54 |
| Return, 1 month / 3 months | −15.3% / −4.5% |
| Return, 1 year / 3 years | +123.2% / +405.5% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 37 |
| Volatility (1 year) | 64.6% |
| Worst drawdown (1 year) | -27.4% |
| Average daily value traded | 41.26M USD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Advanced Micro Devices designs and supplies computer processors and graphics chips. Its central processing units power personal computers, laptops and data-centre servers, while its graphics processors serve gamers, workstations and professional visualisation. The company also builds semi-custom chips for video game consoles and embedded processors for industrial and communications equipment. It is based in the United States and sells to computer makers, cloud operators and consumer hardware brands around the world.
On this site Advanced Micro Devices Inc. appears as a stock on the London Exchange (UK), code 0QZD, with prices in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Advanced Micro Devices Inc. (0QZD) trades on the London Exchange in UK. It last closed at USD 515.85 on 23 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 747 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 123.2% and over the last three months it fell 4.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 78 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 27.6% | ||
| From 52-week high | -21.2% | ||
| Momentum | 78 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | -4.5% | ||
| 6-month return | 67.8% | ||
| 12-month return, skipping the last month | 163.6% | ||
| Stability (higher is calmer) | 35 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 64.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.4% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 41.26M USD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −5.2% |
|---|---|
| 1 month | −15.3% |
| 3 months | −4.5% |
| 6 months | +67.8% |
| 1 year | +123.2% |
| 3 years | +405.5% |
| 5 years | +329.7% |
Signals
| 50-day / 200-day average | 541.56 / 404.43 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 24.80 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.